Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Haque

Showing results (451-460 of 454) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 454 results.
The Lancet. Oncology|June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trialJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Haematologica|March 7, 2024
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignanciesMelissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 31, 2017
The 67P/Churyumov-Gerasimenko observation campaign in support of the Rosetta missionC Snodgrass, M F A'Hearn, F Aceituno, et al.
Pageof 46

Showing results (451-460 of 454) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 454 results.
The Lancet. Oncology|June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trialJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Haematologica|March 7, 2024
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignanciesMelissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 31, 2017
The 67P/Churyumov-Gerasimenko observation campaign in support of the Rosetta missionC Snodgrass, M F A'Hearn, F Aceituno, et al.
Pageof 46